Allopurinol in Acute Gout

Not Applicable

Withdrawn

• Conditions: Gout
• Interventions: Drug: allopurinol

• Registration Number: NCT01775098
• Lead Sponsor: Université de Sherbrooke

Brief Summary

The objectives of the present study are to determine if starting treatement of hyperuricemia with allopurinol during an acute gout crises has an impact on the duration or the severity of the crises

Detailed Description

Not available

Study Timeline

• Primary Completion: 2012-12
• Study First Submitted: 2013-01-21
• Study First Submitted QC: 2013-01-21
• Study First Posted: 2013-01-24
• Study Completion: 2013-02
• Status Verified: 2017-05
• Last Update Submitted: 2017-05-10
• Last Update Posted: 2017-05-11

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

More than 18 years old Able to sign informed consent Indication of long-term treatment with allopurinol Acute gout crisis

Read More

Exclusion Criteria

Les than 18 years-old Unable to consent Contra-indication to allopurinol

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Allopurinol	allopurinol	treatment with allopurinol
placebo	allopurinol	placebo comparator

Primary Outcome Measures

Name	Time	Method
Duration of the gout crises	First 7 days after visit	Presence of inflammatory signs